ATYR

aTyr is a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases are ancient, essential proteins that have evolved novel domains to regulate diverse pathways extracellularly in humans. aTyr's discovery platform is focused on unlocking hidden therapeutic intervention points by uncovering signaling pathways driven by its proprietary library of domains derived from all 20 tRNA synthetases... In addition to efzofitimod, we have a pipeline of therapeutic candidates derived from our tRNA synthetase platform targeting fibrosis and inflammation... Translating tRNA synthetase biology into a new class of medicines.

Also known as: aTyr Pharma, aTyr Pharma Inc.

Primary location: San Diego United States